News

EIT Culture & Creativity launches New Venture Creation call

Published on | 2 weeks ago

Programmes
Culture and society EIT

The European Institute of Innovation and Technology (EIT) Culture & Creativity has launched the Spark call, providing €1.05 million to help early-stage founders turn creative-tech concepts into scalable businesses. Selected individuals and small teams can receive up to €30,000 and join a nine-month programme offering coaching, mentoring, business training and access to a pan-European network.

This call targets technology-driven ventures in materials and the built environment, including fashion, architecture, and advanced or circular materials. Applicants must be based in an EU Member State or Horizon Europe associated country, have no registered company and aim to establish a for-profit, scalable venture. Applications close on 16 November 2026 at 17:00 CET, with online information sessions on 20 October and 10 November. Visit the call webpage for registration and full details.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

2042 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.